echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Bahrain approves the registration of China National Pharmaceutical Group's new crown vaccine

    Bahrain approves the registration of China National Pharmaceutical Group's new crown vaccine

    • Last Update: 2020-12-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medicine Network December 14 Manafort news: Bahrain's National Health Supervision Authority announced on the 13th, officially approved The Chinese National Pharmaceutical Group developed a new crown inactivated vaccine registered in Bahrain.
    Bahraini media reported on the 13th, Bahrain's National Health Supervision Authority said the same day, the decision is based on the vaccine in several countries conducted clinical trial data and a number of authorities review and evaluation.
    The results of the international clinical phase III trial of the new corona inactivated vaccine of China National Pharmaceutical Group showed that after testing 42,299 vaccinated volunteers, the effective rate of the vaccine was 86%, the serum conversion rate of the meso-antibody was 99%, and 100% could prevent the transition of the new coronary to moderate and severe diseases of mild disease.
    Bahrain's National Health Supervision Authority, following a review of scientific data on the vaccine's development and production process and product stability, further verified the quality of the vaccine and confirmed that vaccine manufacturers had fulfilled their commitments to comply with the quality management practices of pharmaceutical production and with international pharmaceutical industry standards and Bahrain's health regulatory authorities.
    Bahrain's National Health Supervision Authority has also consulted the Bahrain Clinical Research Council, which is composed of medical experts, researchers, academics and physicians to approve clinical trials.
    Bahrain's Immune Committee has also approved the vaccine for sale.
    since August 10, more than 7,700 volunteers from Bahrain have signed up for the International Clinical Phase III Trial of The New Coronary Inactivated Vaccine of China National Pharmaceutical Group.
    November 3, Bahrain officially approved voluntary emergency vaccinations for first-line health care workers.
    December 10, Bahrain's Crown Prince and Prime Minister Salman announced that free vaccinations would be given to Bahrainis over the age of 18 and foreigners who have long resided in Bahrain.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.